rare disease data center
Rare Disease Data Center vs Pharma PDFs Exposes Edge
85% of FDA-approved rare disease indications are covered by Alexion’s 2026 pipeline, according to the AAN report. This high coverage gives payers a powerful data-driven edge when they compare it to the aggregated insights from the Rare Disease Data Center. The contrast reveals where real-world data can sharpen coverage